December 30, 2021
Life Sciences
  • The FDA issued an emergency use authorization of an at-home COVID-19 test manufactured by Siemens Healthineers. Acting chief FDA scientist Jacqueline A. O’Shaughnessy wrote that it was “reasonable” to conclude that the Siemens test was “effective in diagnosing COVID-19.” However, the at-home test is unable to differentiate between severe acute respiratory syndrome (SARS) and COVID-19, or SARS-CoV-2. Therefore, “Negative results should be considered in the context of an individual’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19,” O’Shaughnessy wrote. (Article here)